Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Popg
2. Popg, L-
3. Popg, R-
4. 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylglycerol
5. 185435-28-3
6. F72017vpr7
7. L-alpha-1-palmitoyl-2-oleoylglycerophosphoglycerol
8. 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol
9. 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-rac-glycerol
10. 1-hexadecanoyl-2-(9z-octadecenoyl)-sn-glycero-3-phospho-(1'-rac-glycerol)
11. [(2r)-1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] (z)-octadec-9-enoate
12. 9-octadecenoic Acid (9z)-, (1r)-1-((((2,3-dihydroxypropoxy)hydroxyphosphinyl)oxy)methyl)-2-((1-oxohexadecyl)oxy)ethyl Ester
13. 9-octadecenoic Acid (z)-, 1-((((2,3-dihydroxypropoxy)hydroxyphosphinyl)oxy)methyl)-2-((1-oxohexadecyl)oxy)ethyl Ester, (1r)-
14. Pg(16:0/18:1)
15. 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-rac-glycerol Sodium Salt
16. Unii-f72017vpr7
17. 1-hexadecanoyl-2-(9z-octadecenoyl)-sn-glycero-3-phospho-sn-glycerol
18. Chebi:34080
19. Palmitoyloleoyl-phosphatidylglycerol
20. Lmgp04010002
21. 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1'-rac-glycerol)
22. Db11331
23. 1-palmitoyl-2-oleoyl-phosphatidylglycerol
24. Hy-142991
25. Cs-0374728
26. 16:0-18:1 Pg
27. 490h053
28. Q27115796
29. L-.alpha.-1-palmitoyl-2-oleoylglycerophosphoglycerol
30. 1-o-(1-o-palmitoyl-2-o-oleoyl-l-glycero-3-phospho)glycerol
31. {1-hexadecanoyl-2-[(z)-octadec-9-enoyl]-sn-glycero-3-phospho}glycerol
32. (19r)-22,25,26-trihydroxy-16,22-dioxo-17,21,23-trioxa-22lambda(5)-phosphahexacosan-19-yl (9z)-octadec-9-enoate
33. 1-hexadecanoyl-2-[cis-9-octadecanoyl]-sn-glycero-3-[phospho-rac-(1-glycerol)] Ammonium Salt
34. 9-octadecenoic Acid (9z)-, 1-[[[(2,3-dihydroxypropoxy)hydroxyphosphinyl]oxy]methyl]-2-[(1-oxohexadecyl)oxy]ethyl Ester
| Molecular Weight | 749.0 g/mol |
|---|---|
| Molecular Formula | C40H77O10P |
| XLogP3 | 12.3 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 41 |
| Exact Mass | 748.52543565 g/mol |
| Monoisotopic Mass | 748.52543565 g/mol |
| Topological Polar Surface Area | 149 Ų |
| Heavy Atom Count | 51 |
| Formal Charge | 0 |
| Complexity | 868 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Palmitoyloleoyl-phosphatidylglycerol was a component of Surfaxin which was indicated for the prevention of respiratory distress syndrome in premature infants.
FDA Label
Palmitoyloleoyl-phosphatidylglycerol is a replacement surfactant which prevents alveolar collapse when administered intratracheally.
Palmitoyloleoyl-phosphatidylglycerol reduces interfacial tension at the air/water interfaces in the alveoli. This prevents the tension from pulling the alveolar membranes inwards which would collapse them and lead to respiratory distress.
ABOUT THIS PAGE
A Popg, L- manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Popg, L-, including repackagers and relabelers. The FDA regulates Popg, L- manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Popg, L- API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Popg, L- supplier is an individual or a company that provides Popg, L- active pharmaceutical ingredient (API) or Popg, L- finished formulations upon request. The Popg, L- suppliers may include Popg, L- API manufacturers, exporters, distributors and traders.
Popg, L- Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Popg, L- GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Popg, L- GMP manufacturer or Popg, L- GMP API supplier for your needs.
A Popg, L- CoA (Certificate of Analysis) is a formal document that attests to Popg, L-'s compliance with Popg, L- specifications and serves as a tool for batch-level quality control.
Popg, L- CoA mostly includes findings from lab analyses of a specific batch. For each Popg, L- CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Popg, L- may be tested according to a variety of international standards, such as European Pharmacopoeia (Popg, L- EP), Popg, L- JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Popg, L- USP).
LOOKING FOR A SUPPLIER?
